# FDA 483 - BPL Plasma, Inc. - Unknown Date

Source: https://www.keypedia.com/records/483/bpl-plasma-inc/5e489d1f-0f8c-4169-b6a3-d392188a399c

> FDA 483 for BPL Plasma, Inc. on Unknown Date. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BPL Plasma, Inc.
- Product Type: biologics
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
- Summary: An inspection of BPL Plasma, Inc. in El Paso, Texas, revealed that the firm failed to provide complete test results for relevant transfusion-transmitted infections to deferred donors. Specifically, information letters lacked confirmatory or supplemental test results for conditions like syphilis, hepatitis B, anti-HCV, and HIV. This indicates deficiencies in donor counseling and the firm's standard operating procedures.

## Related Officers

- [Christopher C. Wilcox](https://www.keypedia.com/people/christopher-c-wilcox/0c99ef44-6b4d-456e-a84a-995f50c45d64)
- [Judy Ciaraldi](https://www.keypedia.com/people/judy-ciaraldi/118700d5-700a-44bf-a19f-64486c2d0725)

Company: https://www.keypedia.com/companies/bpl-plasma-inc/40ec220a-a78e-4056-80b8-3d795b2952f8

Office: https://www.keypedia.com/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd